Skip to main content

J&J's Ethicon faces Sixth Trial for its Mesh Products

J&J's Ethicon faces Sixth Trial for its Mesh Products

J&J's Ethicon faces Sixth Trial for its Mesh Products

Introduction

J&J's Ethicon faces another pelvic mesh defective product case for two of its mesh products: TVT-SECUR and TVT (tension-free vaginal tape), at the Philadelphia Court of Common Pleas. This is the sixth trial faced by the manufacturer so far. In this latest case, the plaintiff was implanted with a TVT- Secur sling for urinary incontinence in May of 2007, but due to a mid-urethral erosion, she had a corrective surgery done in July 2007, for mid-urethral erosion during which she was implanted with a TVT mesh. However, she underwent three more corrective surgeries following this. The trial is nearing a closure; it's a wait and watch situation; chances loom better for the plaintiff as Philadelphia Court of Common Pleas has passed four earlier pro-plaintiff verdicts and is viewed as favorable to Ethicon transvaginal mesh plaintiffs. Failure to warn about the potential risks and defectively designed are the major allegations faced by Ethicon in this case.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!